Abstracts will be reviewed by a scientific committee and those with the highest scores will be invited to present their work orally as Platform Presentations and remaining accepted abstracts will be invited for Poster Presentations.
Acceptance of an abstract requires an in-person presentation. Authors who are unable to travel to Washington, D.C. may designate a co-author or fellow member of their scientific team to present on their behalf.
Accepted abstracts will be published physically and digitally, constituting public disclosure. For more information on public disclosure as it relates to future publications & patent filings from your research, please consult with your institution’s Technology Transfer/Patenting & Licensing Office.
Acceptance does not include costs of conference registration, travel, or the printing of materials. Please complete your attendee registration for the NF Conference separately.
All NF-relevant abstracts are welcome; however, those aligned with the themes for the 2025 conference will receive a prioritized review. Themes include:
Based on feedback we’ve received from NF Conference attendees, we are changing our abstract submission process to include a more robust categorization of submissions. This will allow us to provide more structure to our assignment of reviewers, placement of posters in the hall, and organization of the abstract book.
In addition to the standard NF type and basic/preclinical vs clinical categories, we have included further categories below.
NF TYPE
